PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,502,658 | -10.1% | 726,298 | +14.1% | 1.42% | +28.4% |
| Q2 2023 | $8,343,309 | +17.1% | 636,408 | -0.2% | 1.10% | +53.3% |
| Q1 2023 | $7,127,395 | -16.8% | 637,513 | -37.3% | 0.72% | +63.1% |
| Q4 2022 | $8,567,055 | -34.0% | 1,016,258 | +30.5% | 0.44% | -41.1% |
| Q3 2022 | $12,978,000 | -33.6% | 778,978 | -41.3% | 0.75% | -33.8% |
| Q2 2022 | $19,534,000 | +33.5% | 1,327,065 | +125.0% | 1.13% | +139.2% |
| Q1 2022 | $14,631,000 | -5.0% | 589,722 | +22.8% | 0.47% | -15.1% |
| Q4 2021 | $15,396,000 | -49.2% | 480,088 | -43.0% | 0.56% | -39.5% |
| Q3 2021 | $30,287,000 | +15.3% | 841,764 | +41.4% | 0.92% | +12.9% |
| Q2 2021 | $26,262,000 | +29.6% | 595,231 | +34.4% | 0.82% | +41.6% |
| Q1 2021 | $20,258,000 | -25.2% | 442,896 | +12.8% | 0.58% | -41.4% |
| Q4 2020 | $27,100,000 | – | 392,642 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |